Mireia Camos

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.

miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.

Journal: Virchows Archiv : an international journal of pathology

Published: November 06, 2025

surviBALL: exploring lncRNA expression at diagnosis for 5-year EFS risk stratification in pediatric B-ALL-a proof of concept.

surviBALL: exploring lncRNA expression at diagnosis for 5-year EFS risk stratification in pediatric B-ALL-a proof of concept.

Journal: Molecular and cellular pediatrics

Published: September 01, 2025

Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.

Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.

Journal: Bone marrow transplantation

Published: August 04, 2025

RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: October 08, 2024

Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

Journal: British journal of haematology

Published: July 04, 2024

Pre-TCR-targeted immunotherapy for T cell acute lymphoblastic leukemia.

Pre-TCR-targeted immunotherapy for T cell acute lymphoblastic leukemia.

Journal: Nature immunology

Published: May 27, 2024

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Blood

Published: May 16, 2024

Maternal Lifestyle and Prenatal Risk Factors for Childhood Leukemia: A Review of the Existing Evidence.

Maternal Lifestyle and Prenatal Risk Factors for Childhood Leukemia: A Review of the Existing Evidence.

Journal: Fetal diagnosis and therapy

Published: February 07, 2024

CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.

CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.

Journal: International journal of molecular sciences

Published: November 10, 2023

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Journal: EMBO molecular medicine

Published: August 05, 2023

The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP).

The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP).

Journal: Frontiers in pediatrics

Published: July 30, 2023

Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.

Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.

Journal: Frontiers in molecular biosciences

Published: January 10, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026